ALKERGOT Drug Patent Profile
✉ Email this page to a colleague
When do Alkergot patents expire, and when can generic versions of Alkergot launch?
Alkergot is a drug marketed by Sandoz and is included in two NDAs.
The generic ingredient in ALKERGOT is ergoloid mesylates. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ergoloid mesylates profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Alkergot
A generic version of ALKERGOT was approved as ergoloid mesylates by SUN PHARM INDUSTRIES on October 31st, 1991.
Summary for ALKERGOT
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 4 |
Patent Applications: | 16 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ALKERGOT at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for ALKERGOT
US Patents and Regulatory Information for ALKERGOT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sandoz | ALKERGOT | ergoloid mesylates | TABLET;SUBLINGUAL | 085153-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sandoz | ALKERGOT | ergoloid mesylates | TABLET;SUBLINGUAL | 087417-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |